Stockreport

Novartis Adds New Therapies As Shares Trade Below Analyst Value Targets [Yahoo! Finance]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Novartis has received European Commission approval for Rhapsido (remibrutinib), the first oral targeted therapy for chronic spontaneous urticaria. The company has als [Read more]